VITASPRING BIOMEDICAL CO. LTD.
AI Executive Summary
AI-powered analysis of 10-Q filing content
VITASPRING BIOMEDICAL is in severe financial distress with zero revenue for nine months, negative $3.2M stockholders' equity, and critically low cash of $2,636. The company has massive related-party debt of $2.4M and accumulated losses of $4.3M, indicating potential going concern issues.
Red Flags Detected (7)
Zero revenue for entire nine months of 2023 vs $1.49M in prior year
Cash depleted from $29,656 to $2,636 (91% decline)
Negative stockholders' equity of $3.2M
4 more red flags detected
Key Takeaways
Company appears to have no active business operations generating revenue
Immediate liquidity crisis with insufficient cash to sustain operations
2 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Quarterly Report: Interim filing with unaudited financial data for the quarter.